| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 01/08/2009 | CA2690753A1 Sulfonamide compound and crystal thereof |
| 01/08/2009 | CA2688313A1 Composition for mucosal administration containing agent for enhancing mucosal absorption of peptide drug, and administration method thereof |
| 01/08/2009 | CA2681813A1 Transcription factor modulating compounds and methods of use thereof |
| 01/08/2009 | CA2660778A1 Near infrared-fluorescence using phospholipid ether analog dyes in endoscopic applications |
| 01/07/2009 | EP2012123A1 Marker for predicting graft-versus-host disease and utilization of the same |
| 01/07/2009 | EP2011877A2 Conjugates for the modulation of immune responses |
| 01/07/2009 | EP2011800A2 Inhibitors of caspase |
| 01/07/2009 | EP2011796A1 Neurogenesis inducer or neuropathy therapeutic agent comprising alkyl ether derivative or salt thereof |
| 01/07/2009 | EP2011788A1 Oxadiazolidinedione compound |
| 01/07/2009 | EP2011513A1 Therapeutic agents for alzheimer's disease and cancer |
| 01/07/2009 | EP2011512A1 An anti HSP90 antibody |
| 01/07/2009 | EP2011505A1 Thioredoxin production promoting agent |
| 01/07/2009 | EP2011501A1 Compounds with chelation affinity and selectivity for first transition series elements and their use |
| 01/07/2009 | EP2011499A2 Pyrrolo[2,3d]Pyrimidine compositions and their use |
| 01/07/2009 | EP2011498A1 Brain function-improving agent, and functional food containing the improving agent |
| 01/07/2009 | EP2011492A1 Gip secretion inhibitor |
| 01/07/2009 | EP2011489A2 Method to inhibit ischemia and reperfusion injury |
| 01/07/2009 | EP2011482A1 Solid preparation for oral application |
| 01/07/2009 | EP2010551A1 Improved treatment of cystic fibrosis |
| 01/07/2009 | EP2010005A1 Treatment of poultry for increasing the feed conversion rate or for reducing the incidence of ascites |
| 01/07/2009 | EP1824472B1 Use of acetyl l-carnitine for the treatment of fibromyalgic syndrome |
| 01/07/2009 | EP1580556B1 Functional domain and associated molecule of dock2 essentially required in lymphocyte migration |
| 01/07/2009 | EP1499277B1 Pyy3-36 for the reduction or prevention of obesity |
| 01/07/2009 | EP1470113B1 Pyrimidinone viral polymerase inhibitors |
| 01/07/2009 | EP1431285B1 Reverse hydroxamic acid derivatives |
| 01/07/2009 | EP1425277B1 Urea-compounds active as vanilloid receptor antagonists for the treatment of pain |
| 01/07/2009 | EP1392662B1 Cdk inhibiting pyrimidines, production thereof and their use as medicaments |
| 01/07/2009 | EP1357909B1 Il-8 receptor antagonists |
| 01/07/2009 | EP1345896B1 Crystalline forms of atorvastatin |
| 01/07/2009 | EP1333024B1 Peptide derivatives and their pharmaceutically acceptable salts, processes for preparation of both, and use thereof |
| 01/07/2009 | EP1246835B1 Substituted sapogenins and their use |
| 01/07/2009 | EP1242103B1 Extracts derived from pueraria mirifica and extraction thereof |
| 01/07/2009 | EP1231895B1 Modular targeted liposomal delivery system |
| 01/07/2009 | EP1204665B1 Chemokine receptor antagonists and methods of use therefor |
| 01/07/2009 | EP0662827B2 Diagnostic methods and pharmaceutical compositions based on notch proteins and nucleic acids |
| 01/07/2009 | CN101341160A Process for production of water-soluble azole prodrug |
| 01/07/2009 | CN101340916A Preparation for external use having improved temporal stability of steroid |
| 01/07/2009 | CN101340913A Agent for preventing or treating pancreas cancer, ovary cancer or liver cancer containing novel water-soluble prodrug |
| 01/07/2009 | CN101337933A Crystal of salt of 4-(3-chloro-4-(cyclopropylaminocarbonyl)amino-phenoxy)-7-methoxy-6-quinolinecarboxamide or of solvate thereof and processes for producing these |
| 01/07/2009 | CN101337932A Crystal of salt of 4-(3-chloro-4-(cyclopropylaminocarbonyl)amino-phenoxy)-7-methoxy-6-quinolinecarboxamide or of solvate thereof and processes for producing these |
| 01/07/2009 | CN101337931A Crystal of salt of 4-(3-chloro-4-(cyclopropylaminocarbonyl)amino-phenoxy)-7-methoxy-6-quinolinecarboxamide or of solvate thereof and processes for producing these |
| 01/07/2009 | CN101336953A Production method of traditional Chinese medicine for treating soft-tissue swell |
| 01/07/2009 | CN101336934A Bear bile buccal tablet and preparation process thereof |
| 01/07/2009 | CN101336929A Medicine for increasing intra-abdominal pressure |
| 01/07/2009 | CN101336887A Drug delivery system using subconjunctival depot |
| 01/07/2009 | CN100448875C Substituted 1-piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof |
| 01/07/2009 | CN100448874C N-aroyl cyclic amines |
| 01/07/2009 | CN100448870C 2-aminoquinoline derivative |
| 01/07/2009 | CN100448868C Tri-substituted heteroaryls and methods of making and using the same |
| 01/07/2009 | CN100448487C Method of treating estrogen receptor positive carcinoma |
| 01/07/2009 | CN100448469C Medicament for treating acute soft tissue injury and its preparation process |
| 01/07/2009 | CN100448454C Cancer treatment composition and method using natural plant essential oils |
| 01/07/2009 | CN100448451C Nutritional compositions with contain slightly negatively charged, non-digestible polysaccharides and use thereof for reducing transport through tight junctions |
| 01/07/2009 | CN100448444C Broadspectrum heterocyclic substituted phenyl containing sulfonamide HIV protease inhibitors |
| 01/07/2009 | CN100448358C Oil/fat composition |
| 01/07/2009 | CN100448348C Relaxation method for nucleated pearl after an operation |
| 01/06/2009 | US7473703 e.g. N-(4-{1-Hydroxy-1-[1-(2-methoxyethyl)-1H-pyrrol-2-yl]-ethyl}-phenyl)-N-methyl-benzenesulfonamide; liver X receptor (LXR) agonist; antidiabetic, antiproliferative agent; lipid, metabolic disorders, obesity, diabetes, hypercholesterolemia, atherosclerosis, hyperlipoproteinemia |
| 01/06/2009 | US7473701 Substituted indazoles, compositions containing them, method of production and use |
| 01/06/2009 | US7473698 Secondary amino anilinic piperidines as MCH1 antagonists and uses thereof |
| 01/06/2009 | US7473692 Sulfonamide derivatives as D3-receptor ligands |
| 01/06/2009 | US7473686 Thrombopoietin mimetics |
| 01/06/2009 | CA2486697C 3'-[(2z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4h-pyrazol-4-ylidene]hydrazino]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid bis-(monoethanolamine) |
| 01/06/2009 | CA2478374C N3 alkylated benzimidazole derivatives as mek inhibitors |
| 01/06/2009 | CA2425812C Treatment of oppositional defiant disorder and conduct disorder with 5-amino-4,5,6,7-tetrahydro-4-oxyindolones |
| 01/06/2009 | CA2421008C Substituted heterocyclic compounds for treating multidrug resistance |
| 01/06/2009 | CA2414095C Novel compounds |
| 01/06/2009 | CA2412541C 9.alpha.-chloro-6.alpha.-fluoro-17.alpha.-hydroxy-16-methyl-17-.beta.-methoxycarbonyl-androst-1,4-dienes esterified in position 17.alpha. by a cyclic acyl group |
| 01/06/2009 | CA2388957C Aromatic di-keto derivatives as glucose-6-phosphate translocase inhibitors |
| 01/06/2009 | CA2380231C Conditionally controlled, attenuated hiv vaccine |
| 01/06/2009 | CA2379086C 1,4,5,6-tetrahydropyrimidine derivative as a vitronectin inhibitor |
| 01/06/2009 | CA2369504C Pyrazole compositions useful as inhibitors of erk |
| 01/06/2009 | CA2347979C Treatment of skin with adenosine or adenosine analog |
| 01/06/2009 | CA2340238C Improved stability for injection solutions |
| 01/06/2009 | CA2295446C Pyrimidinone compounds, pharmaceutical compositions containing the compounds and the process for preparing the same |
| 01/06/2009 | CA2293575C Controlled release microencapsulated ngf formulation |
| 01/06/2009 | CA2288533C New 4-substituted piperidines |
| 01/06/2009 | CA2227851C Novel 2,3-dioxo-1,2,3,4-tetrahydro-quinoyxalinyl derivatives |
| 01/06/2009 | CA2177007C Fluorophenyl-substituted alkenylcarboxylic acid guanidides, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 01/02/2009 | DE60224401T2 Hepatitis c virus polymerase inhibitoren mit heterobicylischer struktur Hepatitis C virus polymerase inhibitors with heterobicylischer structure |
| 01/01/2009 | US20090005580 Compounds, compositions and methods |
| 01/01/2009 | US20090005567 Process for the preparation of 4-(8-chloro-5,6-dihydro-11h-benzo (5,6)-cyclohepta-(1,2b) -pyridin-11-ylidene)-1-piperidinecarboxylic acid ethyl ester (loratadine) |
| 01/01/2009 | US20090005445 Article comprising calcium for reducing the production of TSST-1 |
| 01/01/2009 | US20090005442 Carbamate compounds for use in preventing or treating neurodegenerative disorders |
| 01/01/2009 | US20090005426 Pharmaceutically active sulfonyl hydrazide derivatives |
| 01/01/2009 | US20090005412 Novel quinuclidine derivatives and medicinal compositions containing the same |
| 01/01/2009 | US20090005402 Medicine containing pyrimidine derivative |
| 01/01/2009 | US20090005392 Crystal of 6-[4-(4-pyridylamino) phenyl]-4,5-dihydro-3(2h-pyridazinone hydrochloride trihydrate |
| 01/01/2009 | US20090005349 Therapeutic uses of glutathione mimics |
| 01/01/2009 | US20090005347 Via bisphosphonate drug; for prophylaxis of cartilage destruction or chondrolysis associated with osteonecrosis and/or osteochondritis dissecans |
| 01/01/2009 | US20090005344 Blocking inflammatory cytokines; tumor necrosis factor; phosphodieaterase inhibitor; antiarthritic agents; psoriasis; inflammatory bowel disorders; chronic obstructive pulmonary disorders |
| 01/01/2009 | US20090005333 Reducing culling in herd animals growth hormone releasing hormone (ghrh) |
| 01/01/2009 | US20090005318 Controlled release composition and method of producing the same |
| 01/01/2009 | US20090005316 Alpha-conotoxin mii analogs |
| 01/01/2009 | US20090005304 Human KCNQ5 potassium channel, methods and compositions thereof |
| 01/01/2009 | US20090005294 Peptides for the Treatment of Cancer Associated with the Human Papilloma Virus (HPV) and Other Epithelial Tumors |
| 01/01/2009 | US20090004738 Method and apparatus for maintenance and expansion of hemopoietic stem cells and/or progenitor cells |
| 01/01/2009 | US20090004672 17867, a novel human aminopeptidase |
| 01/01/2009 | US20090004295 Use of a chemically-stabilized chlorite solution for inhibiting an antigen-specific immune response |
| 01/01/2009 | US20090004285 Stable non-disintegrating dosage forms and method of making same |
| 01/01/2009 | US20090004279 Method For Improvement Of Tolerance For Therapeutically Effective Agents Delivered By Inhalation |